ITI-H5L Activators
The functional mechanisms by which ITI-H5L activators exert their influence are diverse yet specific in their action. Compounds that elevate intracellular cyclic AMP (cAMP) levels, such as those that directly stimulate adenylate cyclase or inhibit cAMP degradation, lead to the activation of protein kinase A (PKA). PKA is known for its ability to phosphorylate a wide range of substrates within the cell, and it is through this mechanism that ITI-H5L may undergo phosphorylation, resulting in heightened functional activity. Similarly, activators of protein kinase C (PKC) induce phosphorylation events that can modulate the activity of ITI-H5L, assuming ITI-H5L is a substrate for PKC. The beta-adrenergic pathway, often activated by certain endogenous compounds, also culminates in adenylate cyclase activation and subsequent PKA-mediated phosphorylation, offering another avenue through which ITI-H5L could experience increased activity.
Additionally, signaling molecules that induce calcium influx, such as calcium ionophores, can activate calcium-dependent protein kinases, potentially leading to the modification and activation of ITI-H5L if it is susceptible to calcium-mediated regulation. The PI3K/Akt pathway, a critical signaling axis triggered by insulin among others, involves serine/threonine kinase Akt, which may target ITI-H5L for phosphorylation, thereby influencing its activity. Activation of stress-activated protein kinases, such as those in the SAPK/JNK pathway by specific activators, could also result in the phosphorylation of ITI-H5L. Neurotransmitter signaling via glutamate and modulation of histamine pathways can lead to alterations in intracellular calcium or cAMP, which in turn may activate kinases capable of phosphorylating ITI-H5L. Moreover, modulation of kinase and phosphatase activity by certain molecules that influence cell signaling can also lead to the phosphorylation and activation of ITI-H5L.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels within the cell. Elevated cAMP activates protein kinase A (PKA), which could phosphorylate ITI-H5L, thereby enhancing its activity if ITI-H5L is a substrate for PKA. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). Activation of PKC often leads to phosphorylation of various substrates that can include ITI-H5L, potentially increasing its functional activity through phosphorylation-dependent mechanisms. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that activates adenylate cyclase through G protein-coupled receptor signaling, leading to increased levels of cAMP and subsequent activation of PKA. PKA may phosphorylate ITI-H5L, resulting in its increased activity. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors, triggering a cascade that leads to the activation of adenylate cyclase and an increase in cAMP. This rise in cAMP can activate PKA, which may in turn phosphorylate and activate ITI-H5L. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, enzymes responsible for the breakdown of cAMP. By preventing cAMP degradation, IBMX raises its levels, potentially enhancing PKA activity and the subsequent phosphorylation and activation of ITI-H5L. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the stress-activated protein kinases (SAPKs) such as JNK. Activation of these kinases can lead to the phosphorylation and activation of a variety of downstream proteins, possibly including ITI-H5L if it is a target for these kinases. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which is involved in the regulation of numerous proteins through phosphorylation. Akt, a serine/threonine kinase, may phosphorylate ITI-H5L, enhancing its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. Elevated calcium levels can activate calcium-dependent protein kinases, which could lead to the phosphorylation and activation of ITI-H5L if it is a calcium-dependent protein. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
Acts as a neurotransmitter and can activate receptors linked to intracellular signaling pathways involving calcium or sodium influx, potentially leading to the activation of kinases that phosphorylate and increase the activity of ITI-H5L. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine binds to its G protein-coupled receptors, triggering pathways that can lead to increases in intracellular calcium or cAMP. These signaling molecules can activate kinases that may phosphorylate and activate ITI-H5L. | ||||||